Market Research Logo

Latvia Pharmaceuticals & Healthcare Q1 2019

Latvia Pharmaceuticals & Healthcare Q1 2019

Key View:

Years of underfunding has severely restricted patient access to healthcare services in Latvia and dampenedpharmaceutical sales. The introduction of health insurance will result in a significant boost to public healthcare finances and areduction in out-of-pocket payments. Multinational pharmaceutical firms will thus benefit from increased funding for medicinereimbursement. However, Latvia will remain an insignificant market for drugmakers relative to its EU peers on account of its smallpopulation size.


Key View
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Healthcare Market Forecast
Prescription Drug Market Forecast
Patented Drug Market Forecast
Generic Drug Market Forecast
OTC Medicine Market Forecast
Pharmaceutical Trade Forecast
Industry Risk/Reward Index
Central And Eastern Europe Innovative Pharmaceuticals Risk/Reward Index
Latvia Innovative Pharmaceuticals Risk/Reward Index
Regulatory Development
Regulatory Review
Market Overview
Competitive Landscape
Company Profile
Grindeks
Olainfarm
Latvia Demographic Outlook
Pharmaceuticals & Healthcare Glossary
Pharmaceuticals & Healthcare Methodology

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report